Agenus to Participate in May Investor Conferences
April 24 2023 - 7:30AM
Business Wire
Agenus (NASDAQ: AGEN), a leading immuno-oncology company
specializing in immunological agents for cancer and infectious
diseases, today announced that Dr. Garo Armen, Chairman and CEO,
will participate in the following upcoming investor
conferences:
- HC Wainwright BioConnect Investor Conference – Fireside
chat presentation will be held in-person at NASDAQ Headquarters in
New York City on Tuesday, May 2nd, 2023 at 3:30 PM ET
- EF Hutton Global Conference – 1x1 meetings will be held
in-person at the Plaza Hotel in New York City on Wednesday, May
10th, 2023
A live webcast of the fireside chat from the HC Wainwright
BioConnect Investor Conference can be accessed on the company’s
website at https://investor.agenusbio.com/events-and-presentations.
A replay will be posted following the event.
About Agenus Agenus is a
clinical-stage immuno-oncology company focused on the discovery and
development of therapies that engage the body's immune system to
fight cancer and infections. The Company's vision is to expand the
patient populations benefiting from cancer immunotherapy by
pursuing combination approaches that leverage a broad repertoire of
antibody therapeutics, adoptive cell therapies (through its
subsidiary MiNK Therapeutics), and adjuvants (through its
subsidiary SaponiQx). The Company is equipped with a suite of
antibody discovery platforms and a state-of-the-art GMP
manufacturing facility with the capacity to support clinical
programs. Agenus is headquartered in Lexington, MA. For more
information, please visit www.agenusbio.com and our Twitter handle
@agenus_bio. Information that may be important to investors will be
routinely posted on our website and Twitter.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20230424005051/en/
Agenus Inc. Zack Armen Head of Investor Relations 917-362-1370
zack.armen@agenusbio.com
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From May 2024 to Jun 2024
Agenus (NASDAQ:AGEN)
Historical Stock Chart
From Jun 2023 to Jun 2024